Grenova, an innovator in sustainable laboratory technologies, announced two significant milestones for the company: the appointment of Ted Hull to Grenova's board, and the successful completion of a new round of growth equity capital. These developments support Grenova's strategic vision to drive innovation, expand automation capabilities, and deliver transformative solutions to laboratories worldwide.

The financing was led by Grenova investors, Peloton Equity and Hamilton Lane's (Nasdaq: HLNE) Impact Fund II, along with other existing investors.